- Scrip Originals
- Featured Topics
Already a Biomedtracker subscriber? You have access to the full company record through your subscription
Want to become a subscriber? Subscribers get more company details, updates, company financials and company products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Oculeve Inc.
Execs told Scrip they hope to get Tyrvaya (varenicline) onto formularies and aim for pricing that would make its nasal spray competitive with Restasis and Xiidra.
- Implantable Devices